Characterization of chromatographic yeast extract fractions promoting CHO cell growth
© Mosser et al; licensee BioMed Central Ltd. 2011
Published: 22 November 2011
Many studies underline the great benefits of yeast extracts (YE), used as supplements in animal free culture media, on cell growth and recombinant protein production [1, 2]. Nevertheless, their unknown composition and batch-to-batch variability of commercial YE remain constraints for industrial processes [3, 4]. Consequently, the identification of bioactive YE molecules is challenging for process reliability. The main strategy to respond upon this problem is to fractionate the extract and then to characterize the fractions. So far, several fractionation processes such as ultrafiltration , gel filtration chromatography  or alcoholic precipitation  have been investigated. These studies suggested that the active components were mainly small molecules (< 1000 Da). But, the other physico-chemical properties of YE components have been poorly studied until now. In regards of this statement, it is proposed to get better knowledge of the YE molecules leading to an improvement of CHO cell growth, by implementing various chromatographic fractionation processes.
Material and methods
CHO-AMW cell line producing anti-human RhD-IgG1 was provided by Dr. F. Wurm. Cell growth assays were performed in 96-well plates with 200 μL of working volume inside an incubator at 37 °C and 5 % CO2. Cells were cultivated in a protein-free chemically defined medium RPMI 1640/BDM (90/10) supplemented with 4 mM of glutamine (Eurobio, France) and supplemented or not by 1 g.L-1 of YE fraction. Cell concentration was in-situ monitored by Cellscreen® analyser (Innovatis, Germany).
Operating conditions of preparative chromatographic fractionations.
Gel / Column
Q Sepharose, H 10 cm, ϕ 10 cm
A.1, A.2, A.3
Phenyl Sepharose , H 10 cm, ϕ 5 cm
G-15 Sephadex, H 75 cm H, ϕ 5 cm
W.1, W.2, W.3
Sequentially three step process
same than one step processes
Concentration of total amino acids, polysaccharides and nucleic acids were determined in all fractions by HPLC methods after total hydrolysis. Molecular weights were evaluated by size-exclusion HPLC .
Secondly, YE was divided in 18 fractions by a global process including the three chromatographic methods in a sequential mode: AEC, HIC, GFC. The final GF step presented the advantage to remove the residual salts. The cell growth monitoring pointed out two fractions, which led to similar results than the YE (Figure 1-B). These fractions contained peptides, mainly positively charged and polar, low quantities of polysaccharides but no nucleic acids. The amino acids quantification of fraction A.1-H.1-W.3 underlined that peptides were mainly composed of lysine and arginine. This result was consistent with a recent patent claiming that C-terminal arginine containing tripeptides were at least partially responsible for the growth promoting activity of a peptone (9).
A one step-fractionation process by anion exchange chromatography led to a simplified composition of raw YE without compromising its stimulating effect on CHO cell growth. Furthermore, the three-step fractionation process allowed a better knowledge of the physico-chemical properties of the molecules involved in cell growth stimulating effects: polar positively charged and mainly composed of peptides enriched in arginine and lysine residues.
- Sung YH, Lim SW, Chung JY, Lee GM: Yeast hydrolysate as a low-cost additive to serum-free medium for the production of human thrombopoietin in suspension cultures of Chinese hamster ovary cells. Appl Microbiol Biot. 2004, 63: 527-536. 10.1007/s00253-003-1389-1.View ArticleGoogle Scholar
- Kim DY, Lee JC, Chang HN, Oh DJ: Development of serum-free media for a recombinant CHO cell line producing recombinant antibody. Enzyme Microb Tech. 2006, 39: 426-433. 10.1016/j.enzmictec.2005.11.047.View ArticleGoogle Scholar
- Butler M: Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biot. 2005, 68: 283-291. 10.1007/s00253-005-1980-8.View ArticleGoogle Scholar
- Grillberger L, Kreil TR, Nasr S, Reiter M: Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells. Biotechnol J. 2009, 4: 186-201. 10.1002/biot.200800241.PubMed CentralView ArticlePubMedGoogle Scholar
- Chun BH, Kim JH, Lee HJ, Chung N: Usability of size-excluded fractions of soy protein hydrolysates for growth and viability of Chinese hamster ovary cells in protein-free suspension culture. Bioresource Technol. 2007, 98: 1000-1005. 10.1016/j.biortech.2006.04.012.View ArticleGoogle Scholar
- Mendonça RZ, Oliveira EC, Pereira CA, Lebrun I: Effect of bioactive peptides isolated from yeastolate, lactalbumin and NZCase in the insect cell growth. Bioprocess Biosyst Eng. 2007, 30: 157-164. 10.1007/s00449-006-0099-3.View ArticlePubMedGoogle Scholar
- Shen CF, Kiyota T, Jardin B, Konishi Y, Kamen A: Characterization of yeastolate fractions that promote insect cell growth and recombinant protein production. Cytotechnology. 2007, 54: 25-34. 10.1007/s10616-007-9062-7.PubMed CentralView ArticlePubMedGoogle Scholar
- Chabanon G, Alves da Costa L, Farges B, Harscoat C, Chenu S, Goergen JL, Marc A, Marc I, Chevalot I: Influence of the rapeseed protein hydrolysis process on CHO cell growth. Bioresource Technol. 2008, 99: 7143-7151. 10.1016/j.biortech.2007.12.070.View ArticleGoogle Scholar
- Wilkins J: Biologically active c-terminal arginine-containing peptides. United states patent application. 2009, US 2009/0143248 A1Google Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.